Drug intelligence / Profile preview

dextrose + electrolyte no. 48

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Dextrose + electrolyte no. 48** is a sterile, nonpyrogenic **intravenous crystalloid replacement solution** containing dextrose with a defined electrolyte mixture, classified as **Multiple Electrolytes and Dextrose Injection, Type 1, USP**. The formulation provides water, electrolytes, and calories and is used for **fluid and electrolyte replenishment** and as an **alkalinizing agent**. Per 100 mL, it contains dextrose hydrous, sodium lactate, potassium chloride, magnesium chloride, monobasic potassium phosphate, and sodium chloride. Its effect is not mediated through a single molecular target; rather, it acts as a **supportive replacement therapy** that restores intravascular and extracellular fluid composition, supplies carbohydrate calories, and helps correct acid-base and electrolyte deficits. The product has been manufactured by **Baxter Healthcare**.

Brand names
Dextrose / Electrolytes No. 48
Other names
dextrose + electrolyte no. 485% dextrose and electrolyte no. 48 injectionmultiple electrolytes and dextrose injection type 1

Beyond the preview

Go deeper on dextrose + electrolyte no. 48.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dextrose + electrolyte no. 48.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call